/ARE

Alexandria Real Estate Equities Inc

ARE

$51.14USD↑+3.19%+1.58 today

MARKET CAP

8.9B

P/E (TTM)

—

FWD P/E

—

DAY RANGE

$49 – $51

52W RANGE

$39

$88

AI Summary

Stalk

TrimMedium

ARE remains in a Stage 3 declining regime with a clear medium-term bearish bias and neutral short-term execution conditions. Price is consolidating around the flat, declining EMAs and below both the 50-day and 200-day SMAs. With no active bullish patterns and short-term readiness muted, execution favors trimming on rallies into the EMAs/resistance region, preserving downside participation while awaiting clearer continuation signals.

↑95.4% occupancy at 427k RSF San Diego research hub driving rental income.
↑2.12% dividend yield supports income investors amid market volatility.
↓Q2’26 net loss of $(0.43)/share and EPS guide down 13.5%.

Full analysis →

Buying

6

institutions

Selling

7

institutions

New Positions

1

this quarter

Filing Period

Q2 2026

latest 13-F

13-F Holdings

Institution↕	Action↕	Shares Held↕	Value↓	Change↕	Chg %↕	Weight↕
BI Blackrock, Inc. Q2 2026	BUY	21.69 M	1.15 B	+2.00 M	+25.4%	0.02%
AC Aqr Capital Management LLC Q2 2026	BUY	7.65 M	404.20 M	+5.06 M	+235.9%	0.14%
JC Jpmorgan Chase & Co Q2 2026	SELL	1.43 M	79.63 M	+-2.18 M	-52.3%	0.00%
CA Citadel Advisors LLC Q2 2026	SELL	865.19 K	45.73 M	+-185.31 K	-6.2%	0.01%
MM Millennium Management LLC Q2 2026	SELL	682.83 K	36.09 M	+-107.03 K	-1.6%	0.01%
BA Balyasny Asset Management L.P. Q2 2026	BUYNEW	536.29 K	28.34 M	+536.29 K	+0.0%	0.04%
CP California Public Employees Retirement System Q2 2026	SELL	250.62 K	13.25 M	+-3.31 K	+12.4%	0.01%
JH Janus Henderson Group Plc Q1 2026	BUY	145.11 K	6.73 M	+128.46 K	+726.3%	0.00%
MG Man Group Plc Q2 2026	SELL	94.50 K	4.99 M	+-142.09 K	-54.5%	0.01%
BH Brevan Howard Capital Management LP Q2 2026	BUY	26.79 K	1.42 M	+8.65 K	+68.1%	0.01%
WP Woodline Partners LP Q2 2026	SELL	25.30 K	1.34 M	+-23.63 K	-41.1%	0.00%
RC Rockefeller Capital Management L.P. Q2 2026	BUY	9.82 K	518.88 K	+1.79 K	+39.3%	0.00%
PA Point72 Asset Management, L.P. Q2 2026	SELL	0.00	0.00	+-108.48 K	-100.0%	0.00%